TissueMark imaging algorithms automatically annotate the tumor boundary for you. This can be used to provide a tissue map for macrodissection. TissueMark also measures the percent of tumor nuclei to ensure sample quality and sufficient tumor nucleic acid for molecular profiling.
Support streamlining the evaluation of new molecular assays by automating the markup and tumor cell content in H&E samples. This enables you to make the adoption of new molecular tests practical and cost effective.
Instil accuracy and consistency
Opens the pathway to significantly improve workflow and establish accuracy, consistency and quality in molecular pathology.
Improve turnaround time
Biomarker discovery in solid tumors is accelerated, this could significantly speed up the turnaround time for macrodissection in large studies.
¹ TissueMark is a research application and not for use in diagnostic procedures.
² PathXL is the legal manufacturer of TissueMark and is a Philips company.
By clicking on the link, you will be leaving the official Royal Philips Healthcare ("Philips") website. Any links to third-party websites that may appear on this site are provided only for your convenience and in no way represent any affiliation or endorsement of the information provided on those linked websites. Philips makes no representations or warranties of any kind with regard to any third-party websites or the information contained therein.